Loading clinical trials...
Loading clinical trials...
The purposes of this study are to test whether GAD vaccination can stop the progression of newly diagnosed type 1 diabetes, to describe the related immunological processes (insulitis) in pancreas and ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Oslo University Hospital
NCT04638647 · Autoimmunity, Inflammation
NCT07011147 · Type 1 Diabetes (T1D), Type 2 Diabetes, and more
NCT04119713 · Autoimmunity, Cancer, and more
NCT05894746 · Diabetes, Celiac Disease, and more
NCT06591260 · Myocarditis, Ventricular Arrhythmia, and more
Endokrinologisk poliklinikk, Oslo Universitetssykehus Aker
Oslo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions